From Mumbai to Bangalore, Delhi to Hyderabad, Epitalon is gaining traction for its potential to extend lifespan, repair DNA, protect telomeres, enhance sleep, and even reverse visible signs of aging
Individuals aged 60 years and prescribed injectable GLP1 receptor agonists (except weight loss formulations of liraglutide or semaglutide), SGLT2 inhibitors, or DPP4 inhibitors entered the cohort study
The contracts are long, technically complex, and structured to prevent independent auditing
Is the GLP-1 Gold Rush Facing a Low-Cost Reckoning
Here is the critical conversion to memorize
The consistent finding is reduced neuronal damage and improved functional recovery on standardized scoring scales